GlassScriptPhysician profile
Michael Andrew Deehan
NPI 1306857461
$2,391.90
in general payments reported to CMS, 2019-2025
31 companies · $359 in 2025
The $359 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $204 · 2021: $285 · 2022: $478 · 2023: $90.76 · 2024: $564 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,013.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $695.50 | 2019-2025 | Inspace, Mako, Alphavent |
| Zimmer Biomet Holdings, INC. | $223.83 | 2021-2025 | Timberline Mpf Lateral Modular Plate Fixation System, Tapestry |
| Depuy Synthes Sales INC. | $215.77 | 2019-2023 | Attune, Orthovisc |
| Globus Medical, INC. | $195.13 | 2022 | |
| Bioventus LLC | $129.24 | 2019-2024 | Durolane |
| Endo Pharmaceuticals INC. | $118.23 | 2019-2024 | Xiaflex |
| Horizon Therapeutics Plc | $116.81 | 2019-2021 | |
| Smith+Nephew, INC. | $80.10 | 2020 | |
| Pacira Therapeutics, INC. | $71.22 | 2019-2021 | |
| Spr Therapeutics, INC | $68.03 | 2024 | Sprint Pns System |
| Davol INC. | $42.92 | 2021 | |
| Abbott Laboratories | $38.54 | 2021-2022 | |
| Pfizer INC. | $29.70 | 2019-2020 | |
| Ermi LLC | $27.44 | 2023 | |
| Orthofix Medical, INC. | $26.79 | 2024 | Physio-Stim |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossur Americas, INC. | $24.57 | 2024 | Miami J |
| Baudax Bio INC. | $24.29 | 2022 | |
| Avanos Medical | $23.73 | 2019 | |
| Heraeus Medical, LLC. | $23.73 | 2023 | Palacos |
| Nalu Medical, INC. | $23.13 | 2024 | Nalu Neurostimulation System |
| Fidia Pharma USA INC. | $22.85 | 2019 | |
| Baxter Healthcare | $22.46 | 2022 | |
| Heron Therapeutics, INC. | $20.51 | 2021 | |
| Solventum Corporation | $19.40 | 2025 | Prevena |
| Kci USA, INC. | $18.31 | 2020 | |
| Orthogenrx INC. | $16.89 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.51 | 2024 | Zilretta, Iovera |
| Vertical Pharmaceuticals, LLC | $14.99 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.91 | 2022 | |
| Amgen INC. | $13.85 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Deehan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.